Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

被引：168

作者：

Duong, Hien K. ^{[1
]}

Savani, Bipin N. ^{[2
]}

Copelan, Ed ^{[3
]}

Devine, Steven ^{[4
]}

Costa, Luciano J. ^{[5
]}

Wingard, John R. ^{[6
]}

Shaughnessy, Paul ^{[7
]}

Majhail, Navneet ^{[1
]}

Perales, Miguel-Angel ^{[8
,9
]}

Cutler, Corey S. ^{[10
]}

Bensinger, William ^{[11
]}

Litzow, Mark R. ^{[12
]}

Mohty, Mohamad ^{[13
]}

Champlin, Richard E. ^{[14
]}

Leather, Helen ^{[6
]}

Giralt, Sergio ^{[8
,9
]}

Carpenter, Paul A. ^{[11
]}

机构：

[1] Cleveland Clin Fdn, Blood & Marrow Transplant Program, Dept Blood & Marrow Transplant, Cleveland, OH 44195 USA

[2] Vanderbilt Univ, Med Ctr, Div Hematol & Oncol, Nashville, TN USA

[3] Carolinas HealthCare Syst, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA

[4] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA

[5] Med Univ S Carolina, Dept Med, Div Hematol & Oncol, Charleston, SC 29425 USA

[6] Univ Florida, Hlth Canc Ctr, Div Hematol Oncol, Gainesville, FL USA

[7] Texas Transplant Inst, Dept Adult Bone Marrow Transplant, San Antonio, TX USA

[8] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplantat Serv, New York, NY 10021 USA

[9] Weill Cornell Med Coll, New York, NY USA

[10] Dana Farber Canc Inst, Dept Hematol Oncol, Boston, MA 02115 USA

[11] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA

[12] Mayo Clin, Div Palliat Med, Div Hematol, Rochester, MN USA

[13] St Antoine Hosp, Dept Haematol, Paris, France

[14] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Houston, TX 77030 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 09期

关键词：

Peripheral blood; Progenitor cell mobilization; Hematopoietic transplantation; COLONY-STIMULATING FACTOR; LARGE-VOLUME LEUKAPHERESIS; VERSUS-HOST-DISEASE; NON-HODGKINS-LYMPHOMA; FACTOR G-CSF; PLUS G-CSF; STEM-CELLS; MULTIPLE-MYELOMA; PEDIATRIC-PATIENTS; NORMAL DONORS;

D O I：

10.1016/j.bbmt.2014.05.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Peripheral blood progenitor cell mobilization practices vary significantly among institutions. Effective mobilization regimens include growth factor alone, chemotherapy and growth factor combined, and, more recently, incorporation of plerixafor with either approach. Many institutions have developed algorithms to improve stem cell mobilization success rates and cost-effectiveness. However, an optimal stem cell mobilization regimen has not been defined. Practical guidelines are needed to address important clinical questions, including which growth factor is optimal, what chemotherapy and dose is most effective, and when to initiate leukapheresis. We present recommendations, based on a comprehensive review of the literature, from the American Society of Blood and Marrow Transplantation. (C) 2014 American Society for Blood and Marrow Transplantation.

引用

页码：1262 / 1273

页数：12

共 115 条

[1] The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation [J].

Al-Ali, H. K. ;

Bourgeois, M. ;

Krahl, R. ;

Edel, E. ;

Leiblein, S. ;

Poenisch, W. ;

Basara, N. ;

Lange, T. ;

Niederwieser, D. .

BONE MARROW TRANSPLANTATION, 2011, 46 (10) :1296-1302

[2] Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim:: the M.D. Anderson Cancer Center experience [J].

Anderlini, P ;

Donato, M ;

Chan, KW ;

Huh, YO ;

Gee, AP ;

Lauppe, MJ ;

Champlin, RE ;

Körbling, M .

TRANSFUSION, 1999, 39 (06) :555-560

[3] Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF [J].

Basak, G. W. ;

Wiktor-Jedrzejczak, W. ;

Apperley, J. F. ;

Douglas, K. W. ;

Gabriel, I. H. ;

Geraldes, C. ;

Huebel, K. ;

Jaksic, O. ;

Koristek, Z. ;

Lanza, F. ;

Lemoli, R. ;

Mikala, G. ;

Selleslag, D. ;

Worel, N. ;

Mohty, M. ;

Duarte, R. F. .

BONE MARROW TRANSPLANTATION, 2012, 47 (07) :1003-1005

[4] The number of CD34+cells in peripheral blood as a predictor of the CD34+yield in patients going to autologous stem cell transplantation [J].

Basquiera, A. L. ;

Abichain, P. ;

Damonte, J. C. ;

Ricchi, B. ;

Sturich, A. G. ;

Palazzo, E. D. ;

Garcia, J. J. .

JOURNAL OF CLINICAL APHERESIS, 2006, 21 (02) :92-95

[5] FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS [J].

BENSINGER, W ;

APPELBAUM, F ;

ROWLEY, S ;

STORB, R ;

SANDERS, J ;

LILLEBY, K ;

GOOLEY, T ;

DEMIRER, T ;

SCHIFFMAN, K ;

WEAVER, C ;

CLIFT, R ;

CHAUNCEY, T ;

KLARNET, J ;

MONTGOMERY, P ;

PETERSDORF, S ;

WEIDEN, P ;

WITHERSPOON, R ;

BUCKNER, CD .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2547-2555

[6] Large volume leukapheresis: Efficacy and safety of processing patient's total blood volume six times [J].

Bojanic, Ines ;

Dubravcic, Klara ;

Batinic, Drago ;

Cepulic, Branka Golubic ;

Mazic, Sanja ;

Hren, Darko ;

Nemet, Damir ;

Labar, Boris .

TRANSFUSION AND APHERESIS SCIENCE, 2011, 44 (02) :139-147

[7] Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies [J].

Bolwell, B. J. ;

Pohlman, B. ;

Rybicki, L. ;

Sobecks, R. ;

Dean, R. ;

Curtis, J. ;

Andresen, S. ;

Koo, A. ;

Mineff, V. ;

Kalaycio, M. ;

Sweetenham, J. W. .

BONE MARROW TRANSPLANTATION, 2007, 40 (05) :437-441

[8] AMD3100 plus G-CSF can successfully mobilize CD34+cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data [J].

Calandra, G. ;

McCarty, J. ;

McGuirk, J. ;

Tricot, G. ;

Crocker, S-A ;

Badel, K. ;

Grove, B. ;

Dye, A. ;

Bridger, G. .

BONE MARROW TRANSPLANTATION, 2008, 41 (04) :331-338

[9] Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF [J].

callera, Fernando ;

Cavenaghi, Luciana ;

de Melo, Claudio M. T. P. .

TRANSFUSION AND APHERESIS SCIENCE, 2009, 40 (02) :91-95

[10] A randomised study of 10 μg/kg/day (single dose) vs 2 x 5 μg/kg/day (split dose) G-CSF as stem cell mobilisation regimen in high-risk breast cancer patients [J].

Carrión, R ;

Serrano, D ;

Gómez-Pineda, A ;

Díez-Martín, JL .

BONE MARROW TRANSPLANTATION, 2003, 32 (06) :563-567

← 1 2 3 4 5 6 7 8 9 10 →